Beyond Neurosurgery

Longeviti’s mission is to develop innovative solutions for complex brain surgery. These solutions return patients to anatomical normalcy while providing innovative functional neurotechnology.

Leadership

Longeviti was founded by a team of leading medical device industry executives, neuro surgeons, plastic surgeons and biomedical engineers.

Jesse Christopher

CEO and Co-founder

Jesse co-founded Longeviti and is a pioneer in cranial reconstruction technology, with more than 20 years of experience in the medical device industry. He is a member of Governor Wes Moore's Life Sciences Advisory Board for the state of Maryland Department of Commerce and the Greater Baltimore Council.

Denise Genuit

Chief Administrative Officer, VP

Denise has more than two decades of experience in healthcare management and leadership and specializes in HR, contracts, corporate compliance and operations.

Todd Johnson

VP Sales and Marketing

An expert in medical device sales and marketing, Todd has more than 20 years of experience and is considered an innovator for leading the development of a national neurosurgery training program adopted by the SNS.

Brad Rabinovitz

Chief Operating Officer

Brad collaborates with dozens of academic and commercial partners around the world to bring new technologies to fruition. With more than a decade of experience in MedTech, Brad has established expertise commercializing medical devices, applying technologic advances to clinical improvements, and validating derived products from inception through market release. Brad leads a multidisciplinary team of surgeons, medical doctors, mechanical, electrical, materials engineers, regulatory experts, and industry executives.

Corbin Clawson

Director, Research and Development

Corbin is an industry veteran, with more than 10 years of experience in drug delivery and device development.

Lewis (Lew) Parker

Chairman of the Board

As a turnaround specialist with a long history working with medical firms specializing in orthopedics, Lew was the former Chief Financial Officer of Hazleton Laboratories, President of Kirshner Medical, Board Member of Interpore International, DJ Orthopedics, and Co-Founder and Director of K2M (KTWO) and American Osteomedix. In addition to serving as Longeviti’s Chairman of the Board, he also serves as a board member for several public companies and startups and is a strategic adviser to K2M.

John Andres

Board Director and IP Counsel

John has more than thirty years of experience as an attorney and entrepreneur in the medical device industry. In addition to serving on Longeviti’s Board of Directors, John currently also serves on the Board of Directors for Apyx Medical Corporation which is a maker of a surgical device for cosmetic surgery. From 2004 to 2010, John helped found K2M, Inc.; a spinal implant company; and served on the company’s Board of Directors. He started his career in New York with a patent law firm and went in house with U.S. Surgical in 1989.

Gregory Cole

Board Member

Gregory served as CFO of K2M Group Holdings, Inc., NASDAQ KTWO, a spinal implant innovation company for more than 11 years and has also worked as a financial consultant to start-up and development-stage companies in the technology and medical device industries.

Jill Kalman

Board Member

Dr. Jill Kalman joined Northwell in May 2014 as an associate medical director and then became the executive director of Lenox Hill Hospital responsible for the quality of patient care, safety, and day-to-day operations. She currently serves as Senior Vice President, Chief Medical Officer, and Deputy Physician-In-Chief for Northwell Health. Dr. Kalman is an expert in congestive heart failure with extensive publications and background leading several cardiology programs.